Company / Interest Expense
Eloxx Pharmaceuticals, Inc. Interest Expense History
FY2014-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$47.5K
FY2015
5-year range
$47.5K / $47.5K
FY2014-FY2015
Trend
+0.0%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$47,545 in FY2015.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, interest expense increased 0.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2016 | - | - |
| FY2015 | $47.5K | +0.0% |
| FY2014 | $47.5K | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026